Drug Trial Radar · NCT02566928
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
Last checked: Nov 19, 2026Latest source record: Jul 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
278
Planned (sponsor's estimate)
Start
Oct 2015
Primary completion
Nov 2018
Study completion Dec 31, 2018
Sponsor
- Lead sponsor
- Clinical Directors NetworkResearch network
- Sponsor type
- Research network
- Collaborators
- Rockefeller University; Patient-Centered Outcomes Research Institute
- First posted
- Oct 2, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 7 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall goal of the project is to develop and evaluate a home-based intervention to prevent re-infection and transmission of Community-Acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) in patients presenting to primary care with skin or soft tissue infections (SSTIs). Centers for Disease Control (CDC) CA-MRSA guidelines include incision and drainage, antibiotic sensitivity testing and antibiogram-directed prescribing. Re-infections are common, ranging from 16% to 43%, and present significant challenges to clinicians, patients and their families. Several decolonization and decontamination interventions have been shown to reduce Hospital-Acquired MRSA (HA-MRSA) re-infection and transmission in intensive care units. Few studies examine the feasibility and effectiveness of these infection prevention interventions into primary care settings, and none employ Community Health Workers (CHWs) or "promotoras" to provide home visits for education and interventions about decolonization and decontamination. This comparative effectiveness research/patient centered outcomes research builds upon a highly stakeholder-engaged community-academic research and learning collaborative, including practicing clinicians, patients, clinical and laboratory researchers, and barbers/beauticians. Clinical Directors Network (CDN), an established, NIH-recognized best practice Federally Qualified Health Center (FQHC) Practice-based Research Network (PBRN), and The Rockefeller University propose to address this question through the completion of four aims: (1) To evaluate the comparative effectiveness of a CHW/Promotora-delivered home intervention (Experimental Group) as compared to Usual Care (Control Group) on the primary patient-centered and clinical outcome (SSTI recurrence rates) and secondary patient-centered and clinical outcomes (pain, depression, quality of life, care satisfaction) using a two-arm randomized controlled trial (RCT). (2) To understand the patient-level factors (CA-MRSA infection prevention knowledge, self-efficacy, decision-making autonomy, prevention behaviors/adherence) and environmental-level factors (household surface contamination, household member colonization, transmission to household members) that are associated with differences in SSTI recurrence rates. (3) To understand interactions of the intervention with bacterial genotypic and phenotypic variables on decontamination, decolonization, SSTI recurrence, and household transmission. (4) To explore the evolution of stakeholder engagement and interactions among patients and other community stakeholders with practicing community-based clinicians and academic laboratory and clinical investigators over the duration of the study period.
Conditions
- Methicillin-Resistant Staphylococcus Aureus
- Recurrence
- Staphylococcal Skin Infections
- Antibiotic Resistance
Interventions
2% mupirocin ointmentDrug
Index patients and consenting household members will complete a decolonization regimen consisting of twice-daily application of mupirocin ointment to the anterior nares with a sterile cotton applicator for five days.
Chlorhexidine washOther
Index patients and consenting household members will daily daily for five days with chlorhexidine wash.
Hygiene protocolBehavioral
Index patients and consenting household members will be given educational materials and instructed to in the use of hand-washing, surface disinfection, and laundering.
Primary outcomes
What the sponsor says the trial is designed to measure.
- SSTI Recurrence RateTime frame: 3 months
- SSTI Recurrence RateTime frame: 6 months
- SSTI Recurrence RateTime frame: 12 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
NYU Lutheran Family Health Centers
Brooklyn, New York · Recruiting
NYU Lutheran Medical Center Emergency Department
Brooklyn, New York · Recruiting
Coney Island Hospital
Brooklyn, New York · Recruiting
Community Healthcare Network
New York, New York · Recruiting
Metropolitan Hospital Center
New York, New York · Recruiting
Urban Health Plan
The Bronx, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.